KAINOS Laboratories, Inc. (4556.T) — Stock Score Summary

KAINOS Laboratories, Inc. (4556.T) has a MoatMap StockRank of 56/100 based on Quality (48/100), Value (39/100), and Momentum (54/100) factor scores. The current signal is HOLD. KAINOS Laboratories is a micro-cap Japanese diagnostics firm with low liquidity and no clear competitive advantage. It fails the Buffett lens of a durable economic moat and is too small for our global concentrated mandate.

KAINOS Laboratories, Inc. develops, manufactures, and sells diagnostic reagents and clinical laboratory instruments, specializing in biochemistry and immunology. The company's products are widely used in hospitals and testing centers for diagnosing infectious diseases, autoimmune disorders, and genetic conditions. Its competitive moat is sustained by proprietary antibody technologies and long-term supply contracts with major medical institutions.

Key Financial Metrics

Price$14.18
Market Cap$62M
P/E (TTM)21.36
Price/Book3.76
Return on Equity3.1%
Return on Invested Capital11.4%
Debt/Equity66.97
Gross Margin35.0%
Operating Margin5.1%
Revenue Growth1.5%
Dividend Yield2.8%
Free Cash Flow$8K

KAINOS Laboratories, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Japan).

Frequently Asked Questions

What is KAINOS Laboratories, Inc.’s (4556.T) StockRank?
MoatMap’s StockRank for KAINOS Laboratories, Inc. (4556.T) is 56/100, with a Hold signal. It is a composite of Quality (48), Value (39), and Momentum (54) factor ranks across MoatMap’s 19,000+ stock universe.
Does KAINOS Laboratories, Inc. have an economic moat?
KAINOS Laboratories, Inc. (4556.T) has a Quality factor score of 48/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is KAINOS Laboratories, Inc. a buy, hold, or sell?
MoatMap’s current signal for KAINOS Laboratories, Inc. (4556.T) is Hold, based on a StockRank of 56/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is KAINOS Laboratories, Inc. in?
KAINOS Laboratories, Inc. (4556.T) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (Japan).
Browse all ranked stocks4556.T deep dive reportAI ChampionsHow we score stocksSense-check another stock